Business Context and Reporting Period
This Form 8-K is filed by AFH Acquisition X, Inc. (not Bone Biologics Corp) for the reporting period ending July 28, 2014. The registrant is a Delaware corporation headquartered in Beverly Hills, CA. The filing reports on corporate governance amendments effective July 25, 2014.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on legal and governance amendments rather than financial performance.
Material Changes
On July 25, 2014, the Company amended and restated its Certificate of Incorporation and Bylaws in their entirety. These changes were approved by written consent of a majority of shareholders and the Board of Directors. The primary material change involves enhanced specificity regarding the indemnification of directors and officers, including:
- Clarification of parties entitled to indemnification.
- Establishment of procedures for indemnification claims and expense advancement.
- Clarification of limitations on indemnification obligations.
- A provision ensuring that future repeal or modification of these bylaws does not affect indemnification for matters arising prior to such changes.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or outlook. No specific risks or contingencies are disclosed beyond the standard incorporation of the amended documents by reference.
Key Facts for Investor Verification
- Verify the legal identity of the registrant: The filing is for AFH Acquisition X, Inc., not Bone Biologics Corp.
- Confirm the effective date of the Amended Certificate and Bylaws is July 25, 2014.
- Review Exhibits 3.1 and 3.2 for the full text of the amended governance documents.
- Note that no financial data is included in this specific 8-K filing.